Detalles de la búsqueda
1.
Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML.
Blood
; 129(12): 1636-1645, 2017 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-28049642
2.
The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPA.
Blood
; 122(9): 1576-82, 2013 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-23863898
3.
Impact of postremission consolidation chemotherapy on outcome after reduced-intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia in first complete remission: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Cancer
; 120(6): 855-63, 2014 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24338939
4.
Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial.
Blood Adv
; 5(4): 1110-1121, 2021 02 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33616652
5.
Graft-Versus-Leukemia Effect of Allogeneic Stem-Cell Transplantation and Minimal Residual Disease in Patients With Acute Myeloid Leukemia in First Complete Remission.
JCO Precis Oncol
; 1: 1-13, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35172507
6.
In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naïve repertoire.
J Immunol Methods
; 310(1-2): 40-52, 2006 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-16469329
7.
Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro.
Int J Cancer
; 119(2): 317-27, 2006 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16482562
Resultados
1 -
7
de 7
1
Próxima >
>>